65 results
8-K
EX-99.1
ARQT
Arcutis Biotherapeutics Inc
14 May 24
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update
4:06pm
of ZORYVE foam in seborrheic dermatitis has been incredibly well received by healthcare providers and patients, with over 46,000 prescriptions filled
8-K
EX-1.1
ARQT
Arcutis Biotherapeutics Inc
4 Mar 24
Other Events
4:10pm
applicable foreign, federal, state and local healthcare laws, rules and regulations, including, without limitation, (i) the Federal Food, Drug … , and Cosmetic Act (21 U.S.C. §§ 301 et seq.); (ii) all healthcare related fraud and abuse laws, including, without limitation, the federal Anti-kickback Statute
424B5
ARQT
Arcutis Biotherapeutics Inc
1 Mar 24
Prospectus supplement for primary offering
4:06pm
in the structure of healthcare payment systems;
ratings downgrades by any securities analysts who follow our common stock;
the size of our market float
424B5
qumex4iq57memjo
28 Feb 24
Prospectus supplement for primary offering
4:21pm
S-3
EX-1.2
iuqp6
31 Jan 24
Shelf registration
5:22pm
8-K
EX-1.1
lbu7 hox4s3nbc
23 Oct 23
Other Events
4:25pm
424B5
9te995ru1ulkd12
23 Oct 23
Prospectus supplement for primary offering
4:23pm
424B5
pscr2est0yhibn408o
19 Oct 23
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
4qsjvc
19 Oct 23
Results of Operations and Financial Condition
4:02pm
8-K
EX-99.1
5o0f6e78i8e2xs
16 Dec 22
Other Events
4:03pm
8-K
EX-99.1
6u24d7i2oswlq6km2e5g
2 Sep 22
Arcutis Announces Appointment of Neha Krishnamohan to Board of Directors
6:27pm
8-K
oclu2046vhwdd19
2 Sep 22
Arcutis Announces Appointment of Neha Krishnamohan to Board of Directors
6:27pm
8-K
EX-1.1
i3o2g7mog0
5 Aug 22
Other Events
4:02pm